CSS
RNAC icon

Cubist Systematic Strategies’s Cartesian Therapeutics RNAC Stock Holding History

Cubist Systematic Strategies’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,010
Closed -$351K – 3428
2024
Q2 		$351K Buy
+13,010
New +$311K ﹤0.01% 2287
2023
Q2 		– Sell
-609
Closed -$25.4K – 4182
2023
Q1 		$25.4K Buy
+609
New +$28.6K ﹤0.01% 3653
2022
Q4 		– Sell
-2,561
Closed -$126K – 4542
2022
Q3 		$126K Buy
2,561
+588
+30% +$32.3K ﹤0.01% 3942
2022
Q2 		$78K Sell
1,973
-1,112
-36% -$33K ﹤0.01% 4022
2022
Q1 		$114K Sell
3,085
-1,152
-27% -$72.1K ﹤0.01% 3205
2021
Q4 		$414K Buy
4,237
+2,976
+236% +$320K ﹤0.01% 2586
2021
Q3 		$157K Sell
1,261
-1,921
-60% -$232K ﹤0.01% 2646
2021
Q2 		$399K Buy
3,182
+717
+29% +$85.4K ﹤0.01% 2151
2021
Q1 		$335K Buy
2,465
+1,830
+288% +$227K ﹤0.01% 2192
2020
Q4 		$58K Buy
+635
New +$55.1K ﹤0.01% 2454
2020
Q3 		– Sell
-272
Closed -$23K – 2613
2020
Q2 		$23K Buy
272
+211
+346% +$19.1K ﹤0.01% 2311
2020
Q1 		$4K Buy
+61
New +$5.89K ﹤0.01% 2102
2018
Q1 		– Sell
-128
Closed -$38K – 2025
2017
Q4 		$38K Buy
+128
New +$55.9K ﹤0.01% 1794

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's RNAC Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Cartesian Therapeutics (RNAC) in Q3 2024, closing a stake of 13,010 shares — an estimated $351K sold.

Cubist Systematic Strategies first reported a position in RNAC in Q4 2017 and held it in 13 quarters. The position peaked at $414K in Q4 2021. 64 funds tracked by Wall St. Rank hold RNAC as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Cartesian Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 13,010 Cartesian Therapeutics shares in Q3 2024, an estimated $351K.
  • Cubist Systematic Strategies first reported a position in Cartesian Therapeutics in Q4 2017 and held it in 13 quarters.
  • Cubist Systematic Strategies's Cartesian Therapeutics position peaked at $414K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.